Literature DB >> 475358

Mechanism and specificity of action of ribavirin.

M J Browne.   

Abstract

Ribavirin at a concentration of 30 mug/ml added immediately after infection completely inhibited influenza A/Port Chalmers/1/73 (H(3)N(2)) virus hemagglutinin production in infected MDCK cells. Under these conditions, host cell protein synthesis was inhibited by only 10 to 20%. Polyacrylamide gel electrophoresis of [(35)S]methionine-labeled material from virus-infected cultures confirmed that ribavirin inhibited viral but not host cell protein synthesis. In parallel experiments, actinomycin D also preferentially inhibited viral protein synthesis. The possibility that ribavirin inhibited viral protein synthesis as a result of general inhibition of ribonucleic acid synthesis was therefore examined. In uninfected cells, ribavirin at 30 mug/ml inhibited the incorporation of [(14)C]inosine or [(3)H]uridine into ribonucleic acid but stimulated the incorporation of [(3)H]guanosine. The effects noted are consistent with an inhibition of the host cell enzyme inosine 5'-monophosphate dehydrogenase. This suggestion is supported by the finding that addition of guanosine, but not inosine, to the culture medium substantially reversed the antiviral effect of ribavirin. There was no separation between the concentration of ribavirin causing inhibition of influenza A viral protein synthesis or inhibition of MDCK cell ribonucleic acid synthesis, suggesting that ribavirin is not specifically antiviral in this system but inhibits viral protein synthesis as a result of the general inhibition of ribonucleic acid synthesis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 475358      PMCID: PMC352752          DOI: 10.1128/AAC.15.6.747

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  Selective inhibition of influenza virus protein synthesis by inhibitors of DNA function.

Authors:  P D Minor; N J Dimmock
Journal:  Virology       Date:  1977-05-15       Impact factor: 3.616

2.  Synthesis of influenza virus proteins in infected cells: translation of viral polypeptides, including three P polypeptides, from RNA produced by primary transcription.

Authors:  R A Lamb; P W Choppin
Journal:  Virology       Date:  1976-10-15       Impact factor: 3.616

3.  Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate.

Authors:  B Eriksson; E Helgstrand; N G Johansson; A Larsson; A Misiorny; J O Norén; L Philipson; K Stenberg; G Stening; S Stridh; B Oberg
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

4.  The mechanism by which actinomycin D inhibits protein synthesis in animal cells.

Authors:  H L Cooper; R Braverman
Journal:  Nature       Date:  1977-10-06       Impact factor: 49.962

5.  Virazole (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide; a cytostatic agent.

Authors:  W E Müller; A Maidhof; H Taschner; R K Zahn
Journal:  Biochem Pharmacol       Date:  1977-06-01       Impact factor: 5.858

6.  RNA-dependent RNA polymerase activity associated with virions and subviral particles of myxoviruses.

Authors:  N L Chow; R W Simpson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

7.  Studies on the antiviral activity of amantadine hydrochloride.

Authors:  K W Cochran; H F Maassab; A Tsunoda; B S Berlin
Journal:  Ann N Y Acad Sci       Date:  1965-07-30       Impact factor: 5.691

8.  A working hypothesis--virus resistance development as an indicator of specific antiviral activity.

Authors:  E C Herrmann; J A Herrmann
Journal:  Ann N Y Acad Sci       Date:  1977-03-04       Impact factor: 5.691

9.  Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide.

Authors:  R W Sidwell; J H Huffman; G P Khare; L B Allen; J T Witkowski; R K Robins
Journal:  Science       Date:  1972-08-25       Impact factor: 47.728

10.  Inhibition of influenza RNA synthesis by virazole (ribavirin).

Authors:  C Scholtissek
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

View more
  15 in total

Review 1.  Mode of action of microbial bioactive metabolites.

Authors:  V Bethal
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

2.  Inhibition of immune functions by antiviral drugs.

Authors:  W Heagy; C Crumpacker; P A Lopez; R W Finberg
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

3.  Inhibition of influenza virus transcription by 2'-deoxy-2'-fluoroguanosine.

Authors:  M Tisdale; M Ellis; K Klumpp; S Court; M Ford
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

4.  Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds.

Authors:  E De Clercq; M Cools; J Balzarini; R Snoeck; G Andrei; M Hosoya; S Shigeta; T Ueda; N Minakawa; A Matsuda
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

Review 5.  Ribavirin: a clinical overview.

Authors:  H Fernandez; G Banks; R Smith
Journal:  Eur J Epidemiol       Date:  1986-03       Impact factor: 8.082

6.  Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro.

Authors:  Jack T Nguyen; Justin D Hoopes; Minh H Le; Donald F Smee; Amy K Patick; Dennis J Faix; Patrick J Blair; Menno D de Jong; Mark N Prichard; Gregory T Went
Journal:  PLoS One       Date:  2010-02-22       Impact factor: 3.240

7.  Enhancement of activity against influenza viruses by combinations of antiviral agents.

Authors:  F G Hayden; R G Douglas; R Simons
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

8.  Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro.

Authors:  Jack T Nguyen; Justin D Hoopes; Donald F Smee; Mark N Prichard; Elizabeth M Driebe; David M Engelthaler; Minh H Le; Paul S Keim; R Paul Spence; Gregory T Went
Journal:  Antimicrob Agents Chemother       Date:  2009-07-20       Impact factor: 5.191

9.  Effect of ribavirin on Rous sarcoma virus transformation.

Authors:  F J Jenkins; Y C Chen
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

10.  Comparative activities of several nucleoside analogs against influenza A, B, and C viruses in vitro.

Authors:  S Shigeta; K Konno; T Yokota; K Nakamura; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.